Alexandra Zugno

Dr. Alexandra Zugno

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2011 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
LOLarissa de Oliveira
Larissa de Oliveira
DFDaiane B. Fraga
Daiane B. Fraga
RLRenata D. De Luca
Renata D. De Luca
LCLeila Canever
Leila Canever
FGFernando V. Ghedim
Fernando V. Ghedim
AZAlexandra Zugno
Alexandra Zugno

1 February 2014 in Neuroscience
Verified
Journal Article
Closed access
AZAlexandra Zugno
Alexandra Zugno
HCH.L. Chipindo
H.L. Chipindo
AVA.M. Volpato
A.M. Volpato
JBJ. Budni
J. Budni
ASA.V. Steckert
A.V. Steckert
CGC.S. Gama
C.S. Gama

1 January 2010 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LCLeila Canever
Leila Canever
LOLarissa Oliveira
Larissa Oliveira
RLRenata D′Altoé de Luca
Renata D′Altoé de Luca
PCPaulo T. F. Correa
Paulo T. F. Correa
DFDaiane de B. Fraga
Daiane de B. Fraga
AZAlexandra Zugno
Alexandra Zugno
Schizophrenia is a debilitating mental disorder characterized by positive (delusions, hallucinations, disorganized speech) and negative (affective flattering, avolition and social withdrawal) symptoms as well as cognitive deficits. The frequency, severity and topography characterize the disorder as heterogeneous, the pathophysiology of schizophrenia is poorly understood. Sub‐anesthetic doses of ketamine produce hyperactivity, stereotypy and abnormal social interaction and it is used as a model of schizophrenia. In this study, we induced an animal model by acute sub‐anesthetic doses of ketamine and tested different behavioral parameters. We also evaluated the activity of creatine kinase (CK) in brain of rats treated with ketamine. Our results demonstrated that administration of 10, 25 and 50 mg/kg of ketamine induced an increase of covered distance in habituated and non‐habituated rats to the behavioral apparatus. Ketamine administration induced significant social deficits and stereotypic behavioral in all doses tested. Finally we evaluated the effect of different doses of ketamine on creatinine kinase (CK) activity and we observed that CK activity is increased inspecific regions of the brain. Our study suggests that our animal model may be used as a model of schizophrenia and that cerebral energy metabolism might be altered in the brain of schizophrenic patients, probably leading to alterations that might be involved in the pathogenesis of schizophrenia.

1 October 2016 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
AZAlexandra Zugno
Alexandra Zugno
LCLara Canever
Lara Canever
AHAlexandra S. Heylmann
Alexandra S. Heylmann
PWPatrícia G. Wessler
Patrícia G. Wessler
ASAmanda Steckert
Amanda Steckert
JBJosiane Budni
Josiane Budni

26 July 2011 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
PFPollyana Feldhaus
Pollyana Feldhaus
DFDaiane B. Fraga
Daiane B. Fraga
FGFernando V. Ghedim
Fernando V. Ghedim
RLRenata D. De Luca
Renata D. De Luca
TBThiago D. Bruna
Thiago D. Bruna
AZAlexandra Zugno
Alexandra Zugno

24 March 2017 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LCL. Canever
L. Canever
CAC. S. V. Alves
C. S. V. Alves
GMG. Mastella
G. Mastella
LDL. Damázio
L. Damázio
JPJ. V. Polla
J. V. Polla
AZAlexandra Zugno
Alexandra Zugno